This work is licensed under the Creative Commons Attribution 4.0 International License.
Elliott, P. M. 2014 ESC Guidelines on Diagnosis and Management of Hypertrophic Cardiomyopathy. Russian Journal of Cardiology 2015. https://doi.org/10.15829/1560-4071-2015-05-7-57.ElliottP. M.2014 ESC Guidelines on Diagnosis and Management of Hypertrophic CardiomyopathyRussian Journal of Cardiology2015https://doi.org/10.15829/1560-4071-2015-05-7-57.Search in Google Scholar
O’Mahony, C.; Jichi, F.; Pavlou, M.; Monserrat, L.; Anastasakis, A.; Rapezzi, C.; Biagini, E.; Gimeno, J. R.; Limongelli, G.; McKenna, W. J.; Omar, R. Z.; Elliott, P. M.; Ortiz-Genga, M.; Fernandez, X.; Vlagouli, V.; Stefanadis, C.; Coccolo, F.; Sandoval, M. J. O.; Pacileo, G.; Masarone, D.; Pantazis, A.; Tome-Esteban, M.; Dickie, S.; Lambiase, P. D.; Rahman, S. A Novel Clinical Risk Prediction Model for Sudden Cardiac Death in Hypertrophic Cardiomyopathy (HCM Risk-SCD). European Heart Journal 2014. https://doi.org/10.1093/eurheartj/eht439.O’MahonyC.JichiF.PavlouM.MonserratL.AnastasakisA.RapezziC.BiaginiE.GimenoJ. R.LimongelliG.McKennaW. J.OmarR. Z.ElliottP. M.Ortiz-GengaM.FernandezX.VlagouliV.StefanadisC.CoccoloF.SandovalM. J. O.PacileoG.MasaroneD.PantazisA.Tome-EstebanM.DickieS.LambiaseP. D.RahmanS.A Novel Clinical Risk Prediction Model for Sudden Cardiac Death in Hypertrophic Cardiomyopathy (HCM Risk-SCD)European Heart Journal2014https://doi.org/10.1093/eurheartj/eht439.10.1093/eurheartj/eht439Search in Google Scholar
Maron, B. J.; Wolfson, J. K.; Epstein, S. E.; Roberts, W. C. Intramural (“Small Vessel”) Coronary Artery Disease in Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology 1986. https://doi.org/10.1016/S0735-1097(86)80181-4.MaronB. J.WolfsonJ. K.EpsteinS. E.RobertsW. C.Intramural (“Small Vessel”) Coronary Artery Disease in Hypertrophic CardiomyopathyJournal of the American College of Cardiology1986https://doi.org/10.1016/S0735-1097(86)80181-4.10.1016/S0735-1097(86)80181-4Search in Google Scholar
Eng, C. M.; Fletcher, J.; Wilcox, W. R.; Waldek, S.; Scott, C. R.; Sillence, D. O.; Breunig, F.; Charrow, J.; Germain, D. P.; Nicholls, K.; Banikazemi, M. Fabry Disease: Baseline Medical Characteristics of a Cohort of 1765 Males and Females in the Fabry Registry. Journal of Inherited Metabolic Disease 2007. https://doi.org/10.1007/s10545-007-0521-2.EngC. M.FletcherJ.WilcoxW. R.WaldekS.ScottC. R.SillenceD. O.BreunigF.CharrowJ.GermainD. P.NichollsK.BanikazemiM.Fabry Disease: Baseline Medical Characteristics of a Cohort of 1765 Males and Females in the Fabry RegistryJournal of Inherited Metabolic Disease2007https://doi.org/10.1007/s10545-007-0521-2.10.1007/s10545-007-0521-217347915Search in Google Scholar
Wilcox, W. R.; Oliveira, J. P.; Hopkin, R. J.; Ortiz, A.; Banikazemi, M.; Feldt-Rasmussen, U.; Sims, K.; Waldek, S.; Pastores, G. M.; Lee, P.; Eng, C. M.; Marodi, L.; Stanford, K. E.; Breunig, F.; Wanner, C.; Warnock, D. G.; Lemay, R. M.; Germain, D. P. Females with Fabry Disease Frequently Have Major Organ Involvement: Lessons from the Fabry Registry. Molecular Genetics and Metabolism 2008. https://doi.org/10.1016/j.ymgme.2007.09.013.WilcoxW. R.OliveiraJ. P.HopkinR. J.OrtizA.BanikazemiM.Feldt-RasmussenU.SimsK.WaldekS.PastoresG. M.LeeP.EngC. M.MarodiL.StanfordK. E.BreunigF.WannerC.WarnockD. G.LemayR. M.GermainD. P.Females with Fabry Disease Frequently Have Major Organ Involvement: Lessons from the Fabry RegistryMolecular Genetics and Metabolism2008https://doi.org/10.1016/j.ymgme.2007.09.013.10.1016/j.ymgme.2007.09.01318037317Search in Google Scholar
Sims, K.; Politei, J.; Banikazemi, M.; Lee, P. Stroke in Fabry Disease Frequently Occurs before Diagnosis and in the Absence of Other Clinical Events: Natural History Data from the Fabry Registry. Stroke 2009. https://doi.org/10.1161/STROKEAHA.108.526293.SimsK.PoliteiJ.BanikazemiM.LeeP.Stroke in Fabry Disease Frequently Occurs before Diagnosis and in the Absence of Other Clinical Events: Natural History Data from the Fabry RegistryStroke2009https://doi.org/10.1161/STROKEAHA.108.526293.10.1161/STROKEAHA.108.52629319150871Search in Google Scholar
Namdar, M. Electrocardiographic Changes and Arrhythmia in Fabry Disease. Frontiers in Cardiovascular Medicine 2016, 3 (March), 1–6. https://doi.org/10.3389/fcvm.2016.00007NamdarM.Electrocardiographic Changes and Arrhythmia in Fabry DiseaseFrontiers in Cardiovascular Medicine20163March16https://doi.org/10.3389/fcvm.2016.0000710.3389/fcvm.2016.00007480559827047943Search in Google Scholar
Shah, J. S.; Hughes, D. A.; Sachdev, B.; Tome, M.; Ward, D.; Lee, P.; Mehta, A. B.; Elliott, P. M. Prevalence and Clinical Significance of Cardiac Arrhythmia in Anderson-Dabry Disease. American Journal of Cardiology 2005. https://doi.org/10.1016/j.amjcard.2005.05.033.ShahJ. S.HughesD. A.SachdevB.TomeM.WardD.LeeP.MehtaA. B.ElliottP. M.Prevalence and Clinical Significance of Cardiac Arrhythmia in Anderson-Dabry DiseaseAmerican Journal of Cardiology2005https://doi.org/10.1016/j.amjcard.2005.05.033.10.1016/j.amjcard.2005.05.03316169374Search in Google Scholar
Krämer, J.; Niemann, M.; Liu, D.; Hu, K.; MacHann, W.; Beer, M.; Wanner, C.; Ertl, G.; Weidemann, F. Two-Dimensional Speckle Tracking as a Non-Invasive Tool for Identification of Myocardial Fibrosis in Fabry Disease. European Heart Journal 2013. https://doi.org/10.1093/eurheartj/eht098.KrämerJ.NiemannM.LiuD.HuK.MacHannW.BeerM.WannerC.ErtlG.WeidemannF.Two-Dimensional Speckle Tracking as a Non-Invasive Tool for Identification of Myocardial Fibrosis in Fabry DiseaseEuropean Heart Journal2013https://doi.org/10.1093/eurheartj/eht098.10.1093/eurheartj/eht09823520186Search in Google Scholar
Desnick, R. J.; Brady, R.; Barranger, J.; Collins, A. J.; Germain, D. P.; Goldman, M.; Grabowski, G.; Packman, S.; Wilcox, W. R. Fabry Disease, an under-Recognized Multisystemic Disorder: Expert Recommendations for Diagnosis, Management, and Enzyme Replacement Therapy. Annals of Internal Medicine. 2003. https://doi.org/10.7326/0003-4819-138-4-200302180-00014.DesnickR. J.BradyR.BarrangerJ.CollinsA. J.GermainD. P.GoldmanM.GrabowskiG.PackmanS.WilcoxW. R.Fabry Disease, an under-Recognized Multisystemic Disorder: Expert Recommendations for Diagnosis, Management, and Enzyme Replacement TherapyAnnals of Internal Medicine2003https://doi.org/10.7326/0003-4819-138-4-200302180-00014.10.7326/0003-4819-138-4-200302180-0001412585833Search in Google Scholar
Germain, D. P.; Fan, J. Q. Pharmacological Chaperone Therapy by Active-Site-Specific Chaperones in Fabry Disease: In Vitro and Pre-clinical Studies. In International Journal of Clinical Pharmacology and Therapeutics; 2009.GermainD. P.FanJ. Q.Pharmacological Chaperone Therapy by Active-Site-Specific Chaperones in Fabry Disease: In Vitro and Pre-clinical StudiesIn International Journal of Clinical Pharmacology and Therapeutics2009Search in Google Scholar